We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.

Key Record Dates

ClinicalTrials.gov Identifier: NCT04661384
Brief Title: Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

First Submitted : September 16, 2020
First Submitted that Met QC Criteria : December 8, 2020
First Posted : December 10, 2020

Last Update Submitted that Met QC Criteria : March 10, 2023
Last Update Posted : March 13, 2023